CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 47 filers reported holding CONATUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,662,000 | -37.6% | 2,464,807 | 0.0% | 1.10% | -69.6% |
Q4 2018 | $4,264,000 | -70.2% | 2,464,807 | 0.0% | 3.61% | -62.7% |
Q3 2018 | $14,296,000 | +35.5% | 2,464,807 | 0.0% | 9.68% | +136.9% |
Q2 2018 | $10,549,000 | -27.1% | 2,464,807 | 0.0% | 4.09% | -26.7% |
Q1 2018 | $14,468,000 | +49.0% | 2,464,807 | +17.3% | 5.57% | +43.2% |
Q4 2017 | $9,707,000 | +48.3% | 2,101,171 | +76.3% | 3.89% | +21.8% |
Q3 2017 | $6,545,000 | -4.7% | 1,192,080 | 0.0% | 3.19% | +7.1% |
Q2 2017 | $6,866,000 | -0.2% | 1,192,080 | 0.0% | 2.98% | -9.8% |
Q1 2017 | $6,878,000 | +9.5% | 1,192,080 | 0.0% | 3.31% | +11.6% |
Q4 2016 | $6,282,000 | +163.5% | 1,192,080 | 0.0% | 2.96% | +279.6% |
Q3 2016 | $2,384,000 | -2.9% | 1,192,080 | 0.0% | 0.78% | -2.0% |
Q2 2016 | $2,456,000 | -3.7% | 1,192,080 | 0.0% | 0.80% | +0.8% |
Q1 2016 | $2,551,000 | -25.7% | 1,192,080 | 0.0% | 0.79% | +29.0% |
Q4 2015 | $3,433,000 | -35.3% | 1,192,080 | 0.0% | 0.61% | -24.9% |
Q3 2015 | $5,305,000 | -13.6% | 1,192,080 | 0.0% | 0.82% | -20.5% |
Q2 2015 | $6,139,000 | -27.7% | 1,192,080 | 0.0% | 1.03% | -43.3% |
Q1 2015 | $8,488,000 | +1.7% | 1,192,080 | 0.0% | 1.81% | -2.3% |
Q4 2014 | $8,345,000 | +14.4% | 1,192,080 | 0.0% | 1.85% | -22.4% |
Q3 2014 | $7,296,000 | -32.8% | 1,192,080 | 0.0% | 2.39% | -34.6% |
Q2 2014 | $10,860,000 | +11.9% | 1,192,080 | 0.0% | 3.65% | -11.1% |
Q1 2014 | $9,704,000 | +26.2% | 1,192,080 | 0.0% | 4.11% | +65.4% |
Q4 2013 | $7,689,000 | -35.8% | 1,192,080 | 0.0% | 2.48% | -26.5% |
Q3 2013 | $11,980,000 | – | 1,192,080 | – | 3.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|